Reducing Vaccine Hesitancy among Hispanic Parents of COVID-19 Vaccine-Eligible Children
减少有资格接种 COVID-19 疫苗的儿童的西班牙裔家长对疫苗的犹豫
基本信息
- 批准号:10737776
- 负责人:
- 金额:$ 41.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:2 arm randomized control trial2019-nCoVAddressAdolescentAreaAttitudeBehaviorBeliefCOVID-19COVID-19 mortalityCOVID-19 vaccinationCOVID-19 vaccineCessation of lifeChildChildhoodCollaborationsCommunitiesCommunity Health AidesControl GroupsDiseaseDoseEducational workshopElementsEligibility DeterminationEmotionalFamilyFeasibility StudiesFocus GroupsFutureHealthHealth PromotionHealth behaviorHispanicHospitalizationHuman PapillomavirusImmunityImmunizationIndividualInfectionInflammatoryInfluentialsInterventionLegal GuardiansLong COVIDMethodsNational Institute of Child Health and Human DevelopmentNot Hispanic or LatinoOnline SystemsParentsParticipantPatternPerceptionPersuasive CommunicationPlanning TheoryPopulationPublic HealthRandomized, Controlled TrialsRecommendationReportingResearchRisk ReductionSamplingSocial PerceptionSyndromeSystemTarget PopulationsTestingTransportationUpdateVaccinatedVaccinationVaccinesVirusWorkacceptability and feasibilityarmcommunity engagementcostdesigndigitaleffective interventioneffectiveness evaluationethnic minorityexperienceflufuture outbreakhealth communicationimprovedinnovationinsightintervention costmemberpandemic diseasepost interventionpreventracial minorityrecruitsocial normtheoriestoolvaccine acceptancevaccine accessvaccine hesitancywillingness
项目摘要
Project Summary/Abstract
COVID-19 vaccines, currently available to children over six months old, are a powerful method of preventing
new infections and reducing the risk of hospitalization and death due to COVID-19. However, vaccination rates
among Hispanic children remain suboptimal. Lower vaccination rates in children are largely due to parental
vaccine hesitancy. While national health communication experts have suggested using storytelling as an
effective intervention strategy to promote COVID-19 vaccination, we will take the innovative next steps of
creating and evaluating a digital storytelling intervention to reduce Hispanic parental vaccine hesitancy.
Working with community health workers, we will engage Hispanic parents and legal guardians who report
being previously hesitant to vaccinate their child(ren) against COVID-19 to serve as our digital storytellers.
We will ask them to share their stories of conversion in COVID-19 vaccine perspectives to help other
parents and legal guardians overcome their unique concerns and mistrust of COVID-19 vaccines. Guided by
the Theory of Planned Behavior and storytelling as culture-centric health promotion, we propose to (Aim 1)
develop culturally-relevant digital stories (each 2-3 minutes long) with a diverse sample of Hispanic parents
and legal guardians who transformed from being COVID-19 vaccine-hesitant to vaccine-accepting. In Aim 2,
we will assess the feasibility and acceptability of a web-based pilot digital storytelling intervention vs.
information-only control among parents and legal guardians (n=80) of children who are not up-to-update with
COVID-19 vaccine doses. We will also explore pre- to post-intervention changes in vaccine perceptions,
vaccine hesitancy, intentions to vaccinate children against COVID-19, and children’s vaccine uptake at two-
month post-intervention. If our study demonstrates feasibility, acceptability, promising reductions in vaccine
hesitancy, and increases in vaccine uptake, we will conduct a full-scale randomized controlled trial to examine
the effectiveness of the DST intervention to reduce COVID-19 vaccine hesitancy in our target population. This
more extensive study could be used in future DST interventions to increase immunizations (e.g., flu, HPV)
among Hispanic children and adolescents. In addition, our innovative research may provide evidence of
scalable, disseminatable strategies to reduce vaccine hesitancy and can be used for other rapid vaccination
efforts for potential future outbreaks.
项目概要/摘要
COVID-19 疫苗目前可供 6 个月以上的儿童使用,是一种有效的预防方法
新感染并降低因 COVID-19 导致的住院和死亡风险。然而,疫苗接种率
西班牙裔儿童的情况仍然不理想。儿童疫苗接种率较低主要是由于父母的影响
疫苗犹豫。虽然国家健康传播专家建议使用讲故事作为
为了促进 COVID-19 疫苗接种的有效干预策略,我们将采取创新的后续步骤
创建和评估数字讲故事干预措施,以减少西班牙裔父母对疫苗的犹豫。
我们将与社区卫生工作者合作,让报告的西班牙裔父母和法定监护人参与进来
之前犹豫是否要为自己的孩子接种 COVID-19 疫苗,以充当我们的数字故事讲述者。
我们将请他们分享他们从 COVID-19 疫苗角度转变的故事,以帮助其他人
父母和法定监护人克服了他们对 COVID-19 疫苗的独特担忧和不信任。指导者
计划行为理论和讲故事作为以文化为中心的健康促进,我们建议(目标 1)
与不同的西班牙裔父母样本一起开发与文化相关的数字故事(每个故事长 2-3 分钟)
以及从对 COVID-19 疫苗犹豫不决转变为接受疫苗的法定监护人。在目标 2 中,
我们将评估基于网络的试点数字叙事干预与传统干预的可行性和可接受性。
对不了解最新情况的儿童的父母和法定监护人(n=80)进行仅信息控制
COVID-19 疫苗剂量。我们还将探讨干预前后疫苗认知的变化,
对疫苗的犹豫、为儿童接种 COVID-19 疫苗的意愿以及儿童在两岁时的疫苗接种情况
干预后一个月。如果我们的研究证明可行性、可接受性、有希望减少疫苗
犹豫和疫苗接种率的增加,我们将进行全面的随机对照试验来检查
DST 干预措施对减少目标人群对 COVID-19 疫苗犹豫的有效性。这
更广泛的研究可用于未来的药敏试验干预措施,以增加免疫接种(例如流感、HPV)
西班牙裔儿童和青少年。此外,我们的创新研究可能提供以下证据:
可扩展、可传播的策略,可减少疫苗犹豫,并可用于其他快速疫苗接种
为未来可能爆发的疫情做出努力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sunny Wonsun Kim其他文献
Sunny Wonsun Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sunny Wonsun Kim', 18)}}的其他基金
Effects of Digital Stories Intervention on Psychosocial Well-being for Cancer Patients and Caregivers undergoing Hematopoietic Stem Cell Transplantation (HCT)
数字故事干预对接受造血干细胞移植 (HCT) 的癌症患者和护理人员心理健康的影响
- 批准号:
9377379 - 财政年份:2017
- 资助金额:
$ 41.98万 - 项目类别:
相似国自然基金
微米和纳米塑料作用下2019-nCoV抗病毒药物利巴韦林对河蚬的毒性作用机制
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
2019-nCoV感染导致人体淋巴细胞减低机制及其对机体免疫功能影响
- 批准号:82030002
- 批准年份:2020
- 资助金额:135 万元
- 项目类别:专项基金项目
基于人口流动大数据的新型冠状病毒(2019-nCoV)输出感染风险及接触网络传播模型研究
- 批准号:
- 批准年份:2020
- 资助金额:135 万元
- 项目类别:
新型冠状病毒(2019-nCoV)反向遗传系统及啮齿类感染模型的建立与应用
- 批准号:
- 批准年份:2020
- 资助金额:150 万元
- 项目类别:
血必净预防2019-nCoV肺炎发生ARDS及机制研究
- 批准号:82041003
- 批准年份:2020
- 资助金额:135 万元
- 项目类别:专项基金项目
云南驯养野生动物中新型冠状病毒(2019-nCoV)溯源调查与验证
- 批准号:
- 批准年份:2020
- 资助金额:140 万元
- 项目类别:
新型冠状病毒2019-nCoV复制复合体关键蛋白的功能与潜在药物靶点研究
- 批准号:
- 批准年份:2020
- 资助金额:150 万元
- 项目类别:专项基金项目
2019-nCoV蝙蝠及人群代表性流行株致病能力的比较研究
- 批准号:
- 批准年份:2020
- 资助金额:150 万元
- 项目类别:专项基金项目
人新型冠状病毒2019-nCoV受体利用介导的种间传播和感染机制研究
- 批准号:
- 批准年份:2020
- 资助金额:140 万元
- 项目类别:专项基金项目
新型冠状病毒2019-nCoV重要复制加帽酶的工作机制研究
- 批准号:
- 批准年份:2020
- 资助金额:150 万元
- 项目类别:专项基金项目
相似海外基金
COVID-19 Variant Supplement - Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV
COVID-19 变异补充剂 - 以程序化核糖体移码为目标作为针对 2019-nCoV 的治疗策略
- 批准号:
443173 - 财政年份:2021
- 资助金额:
$ 41.98万 - 项目类别:
Operating Grants
Destigmatizing Chinese Communities in the face of 2019-nCoV: Emergency Management Actions to Address Social Vulnerability in Toronto and Nairobi
面对 2019-nCoV,消除华人社区的污名化:解决多伦多和内罗毕社会脆弱性的应急管理行动
- 批准号:
422610 - 财政年份:2020
- 资助金额:
$ 41.98万 - 项目类别:
Operating Grants
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)
任务A38:建立用于筛选2019新型冠状病毒(2019-nCoV)医疗对策的小动物模型
- 批准号:
10330359 - 财政年份:2020
- 资助金额:
$ 41.98万 - 项目类别:
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)
任务A38:建立用于筛选2019新型冠状病毒(2019-nCoV)医疗对策的小动物模型
- 批准号:
10454575 - 财政年份:2020
- 资助金额:
$ 41.98万 - 项目类别:
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)
任务A38:建立用于筛选2019新型冠状病毒(2019-nCoV)医疗对策的小动物模型
- 批准号:
10454574 - 财政年份:2020
- 资助金额:
$ 41.98万 - 项目类别:
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)
任务A38:建立用于筛选2019新型冠状病毒(2019-nCoV)医疗对策的小动物模型
- 批准号:
10579807 - 财政年份:2020
- 资助金额:
$ 41.98万 - 项目类别:
Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV
以程序化核糖体移码为目标作为针对 2019-nCoV 的治疗策略
- 批准号:
422724 - 财政年份:2020
- 资助金额:
$ 41.98万 - 项目类别:
Operating Grants
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)
任务A38:建立用于筛选2019新型冠状病毒(2019-nCoV)医疗对策的小动物模型
- 批准号:
10464972 - 财政年份:2020
- 资助金额:
$ 41.98万 - 项目类别:
Task A38: Establishment of Small Animal Models for Screening MCMs for the 2019 Novel Coronavirus (2019-nCoV)
任务 A38:建立用于筛选 2019 年新型冠状病毒(2019-nCoV)的 MCM 的小动物模型
- 批准号:
10473626 - 财政年份:2020
- 资助金额:
$ 41.98万 - 项目类别:
RAPID Proposal: Psychological distance and risk perception related to the 2019 novel coronavirus (2019-nCoV) outbreak
RAPID提案:与2019年新型冠状病毒(2019-nCoV)爆发相关的心理距离和风险感知
- 批准号:
2020597 - 财政年份:2020
- 资助金额:
$ 41.98万 - 项目类别:
Standard Grant














{{item.name}}会员




